Next Generation News and Research

RSS

Australian teenagers could see declines in life expectancy and more heart problems: Study

Experts warn that the present generation of Australian teenagers could be the first with a decline in life expectancy and an increase in heart disease. This comes from the first comprehensive national study of young Australians since 1985 that shows that a quarter are overweight or obese.

8 Feb 2011

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2010.

8 Feb 2011

VA announces first Ai2 awards under Industry Innovation Competition

Secretary of Veterans Affairs Eric K. Shinseki officially announced today the first VA Innovation Initiative awards under the agency's Industry Innovation Competition, its third competition since it began in early 2010. These four projects will use innovative new technologies in VA facilities to improve the quality of patient care for Veterans. They represent the first of nearly two-dozen more awards to be made in the coming months.

5 Feb 2011

Partek signs distribution agreement with Life Technologies

Partek Incorporated, a global leader in bioinformatics software, announced today the signing of a distribution agreement with Life Technologies Corporation, a provider of next-generation DNA sequencing technology. The agreement makes Partek Genomics Suite available through Life Technologies as a featured solution for analyzing data generated by Life Technologies' next-generation sequencing devices.

5 Feb 2011

NCR fourth-quarter revenue increases 5% to $1.4 billion

NCR Corporation reported financial results today for the three months ended December 31, 2010. Reported revenue of $1.4 billion increased 5 percent from the fourth quarter of 2009 on both an actual and constant currency basis.

3 Feb 2011

New England Biolabs expands line of reagents for sample preparation

New England Biolabs has expanded its line of reagents for sample preparation upstream of next generation sequencing to include NEBNext® Small RNA Sample Prep Set 1 for sequencing on the Illumina® platforms, and NEBNext Small RNA Sample Prep Set 3 for sequencing on LIFE's SOLiD™ platform. These new products offer a new and unique protocol, which results in higher yields and lower adaptor-dimer formation, as compared to other protocols.

From New England Biolabs 3 Feb 2011

DNAnexus announces new cloud-based tools for analyzing large-scale genomic variation datasets

DNAnexus, Inc., a leading provider of cloud-based solutions for analyzing, visualizing, and managing next-generation sequencing data, today announced the availability of a comprehensive set of new informatics tools that enable life science researchers to efficiently analyze and manage large-scale genomic variation datasets in a cloud-based workflow.

3 Feb 2011

Automation protocols for TruSeq kits is now available in Sciclone NGS Workstation

Caliper Life Sciences, today announced that it has developed and optimized automation protocols on its Sciclone NGS Workstation for Illumina's TruSeq DNA and TruSeq RNA sample preparation kits.

3 Feb 2011

SAGE Labs, Cofactor Genomics partner to sequence genomes for six widely used rat strains

Sigma Life Science, the innovative biological products and services business of Sigma-Aldrich®, today announced that its SAGE Labs initiative has partnered with Cofactor Genomics in an effort to sequence genomes for six of the most widely used strains of rat.

3 Feb 2011

Agilent introduces first commercial RNA target enrichment system

Agilent Technologies, Inc., today introduced SureSelect RNA Capture Kits, the first commercial RNA target enrichment system enabling geneticists to focus on specific genomic loci or transcripts of research interest. The RNA capture kits make it possible to precisely measure expression levels of genes of interest and detect allelic-specific expression, splicing events and gene fusions.

3 Feb 2011

FDA approves FSS's FlexStent system IDE for OPEN Trial

Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.

2 Feb 2011

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010, as well as net sales and earnings per share (EPS) guidance for the full year and first quarter 2011.

2 Feb 2011

Brain surgeon partners with NASA's JPL to design high-tech surgical instruments

Internationally renowned brain surgeon Hrayr Shahinian, M.D., a pioneer in minimally invasive brain surgery, has announced that he is teaming with scientists and technologists at NASA's Jet Propulsion Laboratory in Pasadena, Calif., to design the next generation of high-tech surgical instruments - technology that also will be useful for planetary exploration.

2 Feb 2011

Intrexon announces AgBio Division launch and Agarigen acquisition

Intrexon Corporation, a next generation synthetic biology company, today announced the launch of its Agricultural Biotechnology (AgBio) Division in Research Triangle Park, North Carolina and the acquisition of Agarigen, Inc., a North Carolina-based company that has developed a novel, mushroom-based expression platform for the rapid, high yield production of recombinant proteins.

2 Feb 2011

EA sponsors research grant to investigate specific cancers and kinase mutations

Expression Analysis today announced a jointly sponsored research grant for up to eight American Cancer Society Grantees to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing.

2 Feb 2011

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.

1 Feb 2011

Agilent adds BenchBot Robot to line of automated microplate handling equipment

Agilent Technologies Inc. announced today the addition of the BenchBot Robot to its line of automated microplate handling equipment. As part of Agilent's Automation Solutions instrumentation portfolio, the BenchBot complements the Direct Drive Robot and BenchCel Microplate Handler.

1 Feb 2011

Favorable clinical results from Endologix's Nellix technology against EVAR

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm.

1 Feb 2011

$FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma$

FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.

1 Feb 2011

Maxygen initiates Phase I study to evaluate CTLA4-Ig therapeutic for treatment of rheumatoid arthritis

Maxygen, a biotechnology company focused on the development of improved protein drugs, today announced the initiation of a Phase I clinical study to evaluate a next-generation CTLA4-Ig therapeutic that is being developed by Perseid Therapeutics LLC, Maxygen's majority-owned subsidiary, in collaboration with Astellas Pharma Inc. for the treatment of rheumatoid arthritis and potentially other autoimmune indications.

31 Jan 2011

Next Generation News and Research

Australian teenagers could see declines in life expectancy and more heart problems: Study

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

VA announces first Ai2 awards under Industry Innovation Competition

Partek signs distribution agreement with Life Technologies

NCR fourth-quarter revenue increases 5% to $1.4 billion

New England Biolabs expands line of reagents for sample preparation

DNAnexus announces new cloud-based tools for analyzing large-scale genomic variation datasets

Automation protocols for TruSeq kits is now available in Sciclone NGS Workstation

SAGE Labs, Cofactor Genomics partner to sequence genomes for six widely used rat strains

Agilent introduces first commercial RNA target enrichment system

FDA approves FSS's FlexStent system IDE for OPEN Trial

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

Brain surgeon partners with NASA's JPL to design high-tech surgical instruments

Intrexon announces AgBio Division launch and Agarigen acquisition

EA sponsors research grant to investigate specific cancers and kinase mutations

Genzyme's diagnostic products sold to Sekisui Chemical for $265 million

Agilent adds BenchBot Robot to line of automated microplate handling equipment

Favorable clinical results from Endologix's Nellix technology against EVAR

FDA grants Onyx fast track designation for carfilzomib in treatment of relapsed and refractory multiple myeloma

Maxygen initiates Phase I study to evaluate CTLA4-Ig therapeutic for treatment of rheumatoid arthritis

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News